Literature DB >> 14666954

Left ventricular mass in dippers and nondippers with newly diagnosed hypertension.

Paolo Cicconetti1, Sergio Morelli, Caterina De Serra, Veronica Ciotti, Flavia Chiarotti, Manfredi Giusti de Marle, Luigi Ottaviani, Noemi Riolo, Vincenzo Marigliano.   

Abstract

Hypertensive subjects can be subdivided into 2 groups, dippers and nondippers, according to the presence or the lack of a nocturnal fall of blood pressure of more than 10%. Several studies have investigated cardiac organ damage in the 2 groups with discordant results, but they included subjects with different onset, severity, and treatment of hypertension. The authors selected 23 dippers and 17 nondippers affected by newly (< 1 year) diagnosed grades 1 and 2 hypertension, never treated, who underwent 24-hour ambulatory blood pressure monitoring and M-mode echocardiography. They did not find significant differences between the 2 groups as regards the echocardiographic left ventricular and atrial dimensions or regarding the left ventricular mass, left ventricular mass index, or relative wall thickness. Also no significant differences were found in the rate of either left ventricular remodeling or left ventricular hypertrophy. These data suggest that nondipping status is not associated with a higher level of cardiac involvement in the early phases of hypertension compared to dipping status.

Entities:  

Mesh:

Year:  2003        PMID: 14666954     DOI: 10.1177/000331970305400605

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

Review 1.  Night-time blood pressure patterns and target organ damage: a review.

Authors:  Faye S Routledge; Judith A McFetridge-Durdle; C R Dean
Journal:  Can J Cardiol       Date:  2007-02       Impact factor: 5.223

2.  Echocardiographic indices of left ventricular hypertrophy and diastolic function in hypertensive patients with preserved LVEF classified as dippers and non-dippers.

Authors:  Monika Możdżan; Karina Wierzbowska-Drabik; Małgorzata Kurpesa; Ewa Trzos; Tomasz Rechciński; Marlena Broncel; Jarosław D Kasprzak
Journal:  Arch Med Sci       Date:  2013-04-09       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.